Vassilios Gregoriou - Jul 12, 2022 Form 4 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Role
CEO, Chair, Director, 10%+ Owner
Signature
/s/ Vassilios Gregoriou
Stock symbol
ADN
Transactions as of
Jul 12, 2022
Transactions value $
$0
Form type
4
Date filed
7/15/2022, 05:53 PM
Previous filing
Aug 26, 2022
Next filing
Feb 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADN Common Stock Award $0 +175K +2.74% $0.00 6.56M Jul 12, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADN Employee Stock Options (right to buy) Award $0 +175K $0.00 175K Jul 12, 2022 Common Stock 175K $2.74 Direct F3, F4
holding ADN Employee Stock Options (right to buy) 922K Jul 12, 2022 Common Stock 922K $10.36 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs"), representing a contingent right to receive common stock, granted pursuant to Issuer's 2021 Equity Incentive Plan, dated February 4, 2021 (the "Plan").
F2 RSUs are a common stock equivalent that may be settled solely by delivery of an equal number of shares of Issuer's common stock. They vest 25% over four years on each anniversary of the grant date and will be fully vested on July 12, 2026.
F3 Employee stock options (right to buy) ("Options") granted pursuant to the Plan.
F4 Options vest 25% over four years on each anniversary of the grant date and will be fully vested as of July 12, 2026.